Medicines losing patent protection

MonthYear

March 2027

3 medicines lose their last listed patent or exclusivity in March 2027.

Mar 2Abilifyaripiprazole · Otsuka Pharmaceutical Co Ltd
Mar 10Duaveebazedoxifene acetate and estrogens, conjugated · Wyeth Pharmaceuticals LLC
Mar 15Veletriepoprostenol sodium · Actelion Pharmaceuticals US Inc

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits